Safe and effective use of nivolumab for treating lung adenocarcinoma associated with sporadic lymphangioleiomyomatosis: a rare case report

BACKGROUND: Sporadic lymphangioleiomyomatosis (LAM) is a rare form of diffuse parenchymal lung disease. PD-1 blocking antibodies constitute an essential treatment option for advanced non-small-cell lung cancer (NSCLC). The effect of immune checkpoint inhibitors in lymphangioleiomyomatosis patients w...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Pulm Med
Main Authors: Pluvy, Johan, Brosseau, Solenn, Stelianides, Sandrine, Danel, Claire, Nguenang, Marina, Khalil, Antoine, Crestani, Bruno, Zalcman, Gérard, Gounant, Valérie
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2019
Assuntos:
Case Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6329093/
https://ncbi.nlm.nih.gov/pubmed/30634951
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12890-018-0775-5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados